Next 10 |
Theralink Technologies (OTCPK:OBMP) has announced name change and a change of its ticker symbol from "OBMP" to "THER," as announced by the FINRA on its Feb. 24, 2022. As is customary with a ticker symbol change, the CUSIP number for the Co.'s shares was also changed to 88339Q109. In addi...
Theralink® Technologies Announces Change of Ticker Symbol and CUSIP PR Newswire DENVER , Feb. 25, 2022 /PRNewswire/ -- Theralink Technologies (OTC: THER) ("Theralink" or the "Company") announces today that it has received approval for its previou...
Theralink® Technologies Announces an Update on its Securities PR Newswire DENVER , Oct. 22, 2021 /PRNewswire/ -- Theralink Technologies (OTC: OBMP) ("Theralink" or the "Company") , a precision medicine molecular profiling company with a novel ph...
Theralink® Technologies Achieves Major Milestone: California Clinical and Public Health License for its Golden, CO Laboratory PR Newswire DENVER , March 29, 2021 /PRNewswire/ -- Theralink Technologies, Inc. (OTC: OBMP), a precision medicine and molecular...
Theralink® Technologies Moves Closer Toward Changing the Standard of Care for All Women Newly Diagnosed with HER2+ Breast Cancer George Mason University and Rutgers Cancer Institute of New Jersey Name Theralink Technologies as the Commercial Provider of Critical Assay P...
Theralink® Technologies Announces Milestone Event--The Commencement of Testing on its First Patients PR Newswire DENVER , Jan. 27, 2021 /PRNewswire/ -- Theralink® Technologies (OTC: OBMP) ("Theralink" or the "Company") , a precision ...
Theralink® Technologies Issues Letter to Shareholders Provides a year-end recap and vision for the Company's path forward PR Newswire DENVER , Jan. 6, 2021 /PRNewswire/ -- Theralink Technologies (OTC: OBMP) ("Theralink" or the "Company"...
Theralink® Technologies Appoints Thomas Chilcott as Chief Financial Officer PR Newswire DENVER, Sept. 29, 2020 DENVER , Sept. 29, 2020 /PRNewswire/ -- Theralink Technologies (OTC: OBMP) ("Theralink" or the "Company") , a molecular profili...
OncBioMune Pharmaceuticals ([[OBMP]] +7.1%) has changed its corporate name to Theralink Technologies, Inc., effective Thursday, September 24, 2020.Additionally, the number of shares that the Corporation will have the authority to issue has been increased to 12,000,026,667 shares of which 12,0...
Theralink® Technologies Announces Corporate Name Change PR Newswire DENVER, Sept. 24, 2020 DENVER , Sept. 24, 2020 /PRNewswire/ -- Theralink Technologies (OTC: OBMP) ("Theralink" or the "Company"), formerly OncBioMune Pharmaceuticals, Inc. ,...
News, Short Squeeze, Breakout and More Instantly...
OncBioMune Pharmaceuticals Inc Company Name:
OBMP Stock Symbol:
OTCMKTS Market:
Theralink® Technologies Announces Change of Ticker Symbol and CUSIP PR Newswire DENVER , Feb. 25, 2022 /PRNewswire/ -- Theralink Technologies (OTC: THER) ("Theralink" or the "Company") announces today that it has received approval for its previou...
Theralink® Technologies Announces an Update on its Securities PR Newswire DENVER , Oct. 22, 2021 /PRNewswire/ -- Theralink Technologies (OTC: OBMP) ("Theralink" or the "Company") , a precision medicine molecular profiling company with a novel ph...
Theralink® Technologies Achieves Major Milestone: California Clinical and Public Health License for its Golden, CO Laboratory PR Newswire DENVER , March 29, 2021 /PRNewswire/ -- Theralink Technologies, Inc. (OTC: OBMP), a precision medicine and molecular...